91 related articles for article (PubMed ID: 2539056)
21. [In vitro chemosensitivity of lung cancer and other chest tumors evaluated by human tumor colony assay].
Lee K; Kuze F; Hashimura T; Tanigawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2537-43. PubMed ID: 6095761
[TBL] [Abstract][Full Text] [Related]
22. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
23. No correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes.
Boubakari ; Bracht K; Neumann C; Grünert R; Bednarski PJ
Arch Pharm (Weinheim); 2004 Dec; 337(12):668-71. PubMed ID: 15614830
[TBL] [Abstract][Full Text] [Related]
24. Clinical status of carboplatin.
Canetta R; Franks C; Smaldone L; Bragman K; Rozencweig M
Oncology (Williston Park); 1987 Jul; 1(5):61-70. PubMed ID: 3079484
[TBL] [Abstract][Full Text] [Related]
25. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
[TBL] [Abstract][Full Text] [Related]
27. [Effects of recombinant human colony stimulating factor (rh-CSFs) on colony formation of lung cancer cell lines].
Ohsaki Y; Ohe Y; Niimi S; Nakagawa K; Minato K; Bungo M; Sasaki Y; Horichi N; Eguchi K; Saijo N
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):431-3. PubMed ID: 2539057
[No Abstract] [Full Text] [Related]
28. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
[TBL] [Abstract][Full Text] [Related]
29. [Update of human tumor clonogenic assay in carcinoma of the lung].
Kanzawa F
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
[TBL] [Abstract][Full Text] [Related]
30. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E
Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
Hospers GA; Mulder NH; de Jong B; de Ley L; Uges DR; Fichtinger-Schepman AM; Scheper RJ; de Vries EG
Cancer Res; 1988 Dec; 48(23):6803-7. PubMed ID: 2846161
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
34. A fluorine containing bipyridine cisplatin analog is more effective than cisplatin at inducing apoptosis in cancer cell lines.
Elwell KE; Hall C; Tharkar S; Giraud Y; Bennett B; Bae C; Carper SW
Bioorg Med Chem; 2006 Dec; 14(24):8692-700. PubMed ID: 16942881
[TBL] [Abstract][Full Text] [Related]
35. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
36. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
[TBL] [Abstract][Full Text] [Related]
37. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
38. In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin.
Takahashi H; Sasaki Y; Saijo N; Sakurai M; Nakano H; Nakagawa K; Hoshi A; Jett JR; Hong WS
Cancer Chemother Pharmacol; 1987; 19(3):197-200. PubMed ID: 3034444
[TBL] [Abstract][Full Text] [Related]
39. [Cell kinetic studies of the effects of cis-diamminedichloro platinum (II) on lung cancer cell lines].
Ito M; Inoue S; Araya Y; Takaoka K; Miyamoto H; Kawakami Y; Mizuno S
Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2206-15. PubMed ID: 3029253
[No Abstract] [Full Text] [Related]
40. Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro.
Harstrick A; Casper J; Guba R; Wilke H; Poliwoda H; Schmoll HJ
Cancer; 1989 Mar; 63(6):1079-83. PubMed ID: 2645036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
